Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 1.000 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.504 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.476 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.459 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.454 | |
| 5br4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.453 | |
| 3b6z | CO7 | Enoyl reductase LovC | 1 | 0.445 | |
| 2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.443 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.442 |